B 293 Pill - beige oval, 15mm
Pill with imprint B 293 is Beige, Oval and has been identified as Oxcarbazepine 300 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Oxcarbazepine is used in the treatment of Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Oxcarbazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B 293
Oxcarbazepine
- Imprint
- B 293
- Strength
- 300 mg
- Color
- Beige
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- Inactive Ingredients
-
crospovidone,
silicon dioxide,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
titanium dioxide,
FD&C Yellow No. 6,
FD&C Yellow No. 5,
FD&C Blue No. 2,
polyvinyl alcohol,
aluminum oxide,
soya lecithin,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 51991-0293 | Breckenridge Pharmaceutical, Inc. |
| 59746-0622 (Discontinued) | Jubilant Cadista Pharmaceuticals Inc. |
| 68084-0853 (Discontinued) | Amerisource Health Services |
See also:
More about oxcarbazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (384)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Oxcarbazepine drug information
- Oxcarbazepine Extended-Release Tablets
- Oxcarbazepine Tablets
- Oxcarbazepine Oral Suspension
Other brands
Professional resources
- Oxcarbazepine monograph
- Oxcarbazepine (FDA)
- Oxcarbazepine ER Tablets (FDA)
- Oxcarbazepine Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.